Company: CLX
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0000021076-25-000053
Chunk: 43

Company: CLOROX CO /DE/
Filing Date: 2025-11-03
Form: 10-Q
Item: Part II, Item 2
Chunk 43
---
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In May 2018, the Board of Directors authorized the Company to repurchase up to $2,000 million in shares of common stock on the open market (the 2018 Open-Market Program), which has no expiration date.

In August 1999, the Board of Directors authorized a stock repurchase program to reduce or eliminate dilution upon the issuance of common stock pursuant to the Company’s stock compensation plans (the Evergreen Program). In November 2005, the Board of Directors authorized the extension of the Evergreen Program to reduce or eliminate dilution in connection with issuances of common stock pursuant to the Company’s 2005 Stock Incentive Plan. The Evergreen Program has no expiration date and has no specified limit as to dollar amount and therefore is not included in column [d] below.

The following table sets forth the purchases of the Company’s securities by the Company and any affiliated purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3)) during the first quarter of fiscal year 2026. [a][b][c][d]PeriodTotal Number ofShares PurchasedAverage Price Paidper Share (2)Total Number ofShares Purchased asPart of PubliclyAnnounced Plans orPrograms (1)Maximum Number (orApproximate DollarValue) of Shares thatMay Yet Be PurchasedUnder the Plans orProgramsJuly 1 to 31, 2025395,766 $126.34 395,766 $993 millionAugust 1 to 31, 2025652,257 121.25 652,257 $953 millionSeptember 1 to 30, 2025— — — $953 millionTotal1,048,023 $123.22 1,048,023 

(1)  All of the shares purchased in July 2025 were acquired pursuant to the Company’s Evergreen Program. Of the shares purchased in August 2025, 323,173 shares were acquired pursuant to the Company’s Evergreen Program and 329,084 shares were acquired pursuant to the Company’s Open-Market Program.

(2) Average price paid per share in the period includes commission. 

Item 5. Other Information

During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a